Clostridium difficile and Clostridium perfringens research
Type
article
Field-Weighted Citation Impact
18.15
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Fecal Microbiota Transplantation Versus Vancomycin for Primary Clostridioides difficile Infection
Aby Abraham, Trond Egil Ranheim, Erik Riise, Magnus Løberg et al.
Citations
13 citations
Journal
Annals of Internal Medicine
Topics
Clostridium difficile and Clostridium perfringens research
Field-Weighted Citation Impact (FWCI)
18.15
article
Fecal Microbiota Transplantation Versus Vancomycin for Primary Clostridioides difficile Infection
Aby Abraham, Trond Egil Ranheim, Erik Riise, Magnus Løberg, Eirik Hugaas Ofstad, Hilde Skudal, Kjetil Garborg, Trond J. Cooper, Kristian Tonby, Peter Holger Johnsen, Michael Bretthauer, Øyvind Bakken Rognstad, Kurt Hanevik, Kristine Marie Aarberg Lund, Dag Arne Lihaug Hoff, Jørgen Valeur, Frederik Emil Juul, Håvard Wiig, Raziye Boyar Cetinkaya, Eivind Ness‐Jensen, Mette Kalager, Birgitte Seip, Linn Skjevling, Faye Samy, Hans Olov Adami, Jan Erik Berdal, Ida Frivold Glad, Axel E. Nissen-Lie, Ellen J. Melsom
article en
13 citations
Abstract
No abstract available for this paper.
Publication Tag
Annals of Internal MedicineVol. 178(7)
Institutions
Oslo University Hospital (NO), University Hospital of North Norway (NO), Karolinska University Hospital (SE), University of Oslo (NO), Norwegian University of Science and Technology (NO), Stavanger University Hospital (NO), Akershus University Hospital (NO), Levanger Hospital (NO), Vestre Viken Hospital Trust (NO), Haukeland University Hospital (NO), Sykehuset i Vestfold (NO), Karolinska Institutet (SE), Molde Hospital (NO), Nordland Hospital (NO), Kristiansund Sykehus (NO), Frontier Agriculture (United Kingdom) (GB), Diakonhjemmet Hospital (NO), Telemark Hospital (NO), Lovisenberg Diakonale Sykehus (NO), Sørlandet Sykehus (NO), University of Bergen (NO), UiT The Arctic University of Norway (NO)
Sustainable Development Goals
Zero hunger
OpenAlex Percentile
Openalex Percentile: Top 1%
Topics
Clostridium difficile and Clostridium perfringens research